New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganis...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_91188 | ||
005 | 20220812 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220812s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-4735-0 | ||
020 | |a 9783036547367 | ||
020 | |a 9783036547350 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-4735-0 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PN |2 bicssc | |
100 | 1 | |a Felgueiras, Helena |4 edt | |
700 | 1 | |a Felgueiras, Helena |4 oth | |
245 | 1 | 0 | |a New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (232 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganisms, which constitute a major challenge to global health. The antibiotic crisis is now a general concern; therefore, alternative biomolecules or drug delivery systems to treat infections are urgently needed. From natural extracts to traditional medicine remedies, to newly engineered nanocapsules and nanoparticles, to bio-based, biodegradable delivery platforms, many systems to fight infections are explored in this book. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Chemistry |2 bicssc | |
653 | |a nanoparticles | ||
653 | |a 4-Nerolidylcatechol | ||
653 | |a antifungals | ||
653 | |a Microsporum canis | ||
653 | |a polycaprolactone | ||
653 | |a nanoprecipitation | ||
653 | |a silver nanoparticles | ||
653 | |a green synthesis method | ||
653 | |a Catharanthus roseus | ||
653 | |a Azadirachta indica | ||
653 | |a multidrug-resistant bacteria | ||
653 | |a wound healing | ||
653 | |a nosocomial infection | ||
653 | |a plant extract | ||
653 | |a grapefruit seed extract | ||
653 | |a antibacterial activity | ||
653 | |a fiber-hydrogel composite | ||
653 | |a biodegradable polymers | ||
653 | |a skin regeneration | ||
653 | |a drug delivery platforms | ||
653 | |a controlled release | ||
653 | |a tetramycin | ||
653 | |a antimicrobial activity | ||
653 | |a kiwifruit disease | ||
653 | |a conventional antibiotics | ||
653 | |a storage quality | ||
653 | |a gold nanoparticles | ||
653 | |a flavonoids | ||
653 | |a Gram-negative bacteria | ||
653 | |a DNA gyrase | ||
653 | |a in silico | ||
653 | |a multidrug-resistant Acinetobacter baumannii (MDR-AB) | ||
653 | |a hypertonic saline | ||
653 | |a antibiotics | ||
653 | |a biofilm | ||
653 | |a aerosol delivery | ||
653 | |a ultrahigh-throughput screening | ||
653 | |a live biosensors | ||
653 | |a antibiotic discovery | ||
653 | |a gram-negative pathogens | ||
653 | |a microfluidic droplet cocultivation | ||
653 | |a efficient promoters | ||
653 | |a polymyxins | ||
653 | |a colistin biosynthetic gene cluster | ||
653 | |a single cell | ||
653 | |a multi-omics | ||
653 | |a quercetin | ||
653 | |a magnesium-doped calcium silicate | ||
653 | |a osteogenic activity | ||
653 | |a bone regeneration and nanofiber scaffold | ||
653 | |a bulk-tank milk | ||
653 | |a mastitis | ||
653 | |a methicillin | ||
653 | |a milk | ||
653 | |a goat | ||
653 | |a somatic cell counts | ||
653 | |a staphylococcus | ||
653 | |a tetracycline | ||
653 | |a total bacterial counts | ||
653 | |a prosthetic joint infection | ||
653 | |a local prevention | ||
653 | |a allicin | ||
653 | |a chitosan | ||
653 | |a Sphaerotheca sp. | ||
653 | |a antibiotic | ||
653 | |a Rosa roxburghii | ||
653 | |a cyclic diphenylphosphonate | ||
653 | |a quinoline | ||
653 | |a DNA gyrase inhibitor | ||
653 | |a molecular docking | ||
653 | |a magnesium ion | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5834 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/91188 |7 0 |z DOAB: description of the publication |